Literature DB >> 29658351

High estrogen exposure may not be detrimental on endometrial receptivity in women with PCOS.

Cigdem Abide Yayla1, Enis Ozkaya1, Gulay Beydilli Nacak1, Ilhan Sanverdi1, Belgin Devranoglu1, Evrim Bostanci Ergen1, Cetin Kilicci1, Tayfun Kutlu1.   

Abstract

The study aimed to assess the effect of high estrogen exposure and coasting on cycle outcome in women at risk for developing ovarian hyperstimulation syndrome (OHSS). Retrospective case-control study was conducted to figure out the outcomes of GnRH antagonist cycles in which women were at risk to develop OHSS. Women who underwent coasting (n = 100) were compared with a control group of women who did not undergo coasting (n = 287). Effect of endometrial estrogen exposure was determined by calculating area under curve of temporal estrogen measurements (AUCEM) through the cycle. Among 387 women with PCOS, 100 cases were required to undergo coasting to avoid OHSS. All participants reached to embryo transfer stage and clinical pregnancy rate was 44% in group with coasting whereas 39% in group without coasting (p > .05). AUCEM was a significant predictor for the cases who required coasting to avoid OHSS (AUC = 0.754, p < .001). Optimal cut off value was calculated to be 6762 with 71% sensitivity and 67% specificity. ROC analysis showed no predictive value of AUCEM for clinical pregnancy in subgroup of women with coasting (AUC = 0.496, p > .05). Consistently, ROC analysis showed no predictive value of AUCEM for clinical pregnancy in subgroup of women without coasting (AUC = 0.494, p > .05). In conclusion, neither coasting nor the high endometrial estrogen exposure was found to have detrimental effect on endometrial receptivity and cycle outcome in PCOS.

Entities:  

Keywords:  Ovarian hyperstimulation syndrome; endometrial receptivity; estrogen exposure; polycystic ovaries; premature progesterone rise

Mesh:

Substances:

Year:  2018        PMID: 29658351     DOI: 10.1080/09513590.2018.1460344

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  1 in total

1.  Light-initiated chemiluminescent assay of 17β-estradiol metrological traceability system established by manufacturer according to ISO17511:2020 and basic performance evaluation performed by clinical end-users.

Authors:  Chenyu Shang; Xue Yuan; Haibiao Lin; Dongdong Liu; Xiaoxin Yan; Xinxin Ren; Xiyang Lin; Huang Di; Huiqiang Li
Journal:  J Clin Lab Anal       Date:  2022-04-26       Impact factor: 3.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.